Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse


March 28, 2005 28 March, 2005

Pheromone Sciences Corp Announces Appointment of Mr. Dev Randhawa, MBA, as President and CEO & Director.


Toronto, Ontario - March 28, 2005: Pheromone Sciences Corp. (TSX-V:PHS) today announced that Mr. Dev Randhawa MBA, President and CEO of Strathmore Minerals and a past director of Medicure, will assume the position of President and CEO of the company. Mr. Randhawa will also join the Board of Pheromone Sciences.

Dr. William Cochrane, Chairman of Pheromone Sciences stated, "We are fortunate that Mr. Christopher Newman, the former President and CEO of the company has agreed to remain on the board of Pheromone Sciences Corp. to assure an orderly transition. We thank Mr. Newman for all his hard work and contribution to the development of the company and its technology and are happy that he will continue to provide input based upon his many years of healthcare experience."

Statements contained in this press release, including those pertaining to scientific and clinical research, commercialization plans, strategic alliances, and intellectual property protection, other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made. The TSX Ventures Exchange has not reviewed and does not accept responsibility for the adequacy or the contents of this news release.

144 Front Street West, Suite 360 Toronto , Ontario, Canada M5J 2L7 Tel: (416) 861-9854 Fax: (416) 861-9950

INVESTOR CONTACT William Cochrane (403) 270-2438 investor@pheromonesciences.com